Ticker
2CUREX.ST

Price
8.13
Stock movement down
-0.02 (-0.25%)
Company name
2cureX AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
143.11M
Ent value
98.89M
Price/Sales
17888.95
Price/Book
2.82
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-51.89%
3 year return
-15.02%
5 year return
2.34%
10 year return
-
Last updated: 2023-02-01

DIVIDENDS

2CUREX.ST does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales17888.95
Price to Book2.82
EV to Sales12361.82

FINANCIALS

Per share

Loading...
Per share data
Current share count17.60M
EPS (TTM)-1.64
FCF per share (TTM)-1.46

Income statement

Loading...
Income statement data
Revenue (TTM)8.00K
Gross profit (TTM)-14.13M
Operating income (TTM)-32.36M
Net income (TTM)-28.86M
EPS (TTM)-1.64
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-176600.00%
Operating margin (TTM)-214748.36%
Profit margin (TTM)-214748.36%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash47.82M
Net receivables5.63M
Total current assets53.45M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets54.27M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities3.60M
Total liabilities3.60M
Shareholder's equity50.67M
Net tangible assets50.67M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-25.74M
Capital expenditures (TTM)32.00K
Free cash flow (TTM)-25.77M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-56.96%
Return on Assets-53.18%
Return on Invested Capital-56.96%
Cash Return on Invested Capital-50.87%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open8.37
Daily high8.37
Daily low7.54
Daily Volume13K
All-time high28.20
1y analyst estimate-
Beta0.74
EPS (TTM)-1.64
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
2CUREX.STS&P500
Current price drop from All-time high-71.17%-14.91%
Highest price drop-73.09%-56.47%
Date of highest drop22 Nov 20229 Mar 2009
Avg drop from high-31.74%-11.49%
Avg time to new high57 days13 days
Max time to new high497 days1805 days
COMPANY DETAILS
2CUREX.ST (2cureX AB) company logo
Marketcap
143.11M
Marketcap category
Small-cap
Description
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
Employees
14
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found